Home » Topics » BioWorld Science

BioWorld Science
RSS

Remdesivir receives Japanese approval for severe COVID-19

May 8, 2020

Novel variant in the SLC6A3 gene is linked to PKDYS1 phenotype

May 8, 2020

First-in-human data for SDX-7320 in advanced refractory or late-stage solid tumors

May 8, 2020

Genentech reports phase Ib data for UTTR-1147A

May 8, 2020

Health Canada clears phase I trial of AC-1101 for vitiligo

May 8, 2020

RBN-2397: a first-in-class PARP-7 inhibitor with oral antitumor activity

May 8, 2020

Pfizer presents phase II data for PF-06480605 in ulcerative colitis

May 8, 2020

MGH reports progress in development of a novel gene-based COVID-19 vaccine

May 8, 2020

Positive preclinical data support IND application for CardiALLO therapy in heart failure

May 8, 2020

FDA approves IND for Organicell Flow as treatment of SARS due to COVID-19

May 8, 2020

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...